Insiders / Dambkowski Carl / Activity
Activity — Dambkowski Carl
23 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 7, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $1.15M | -15K -6.49% | 213,449 0.28% of shares | medium |
| Aug 5, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $737.9K | -6K -3.16% | 168,498 0.22% of shares | medium |
| Jan 7, 2026 | Exercise | APGE Apogee Therapeutics, Inc. Common Stock | $320.6K | +14K +6.46% | 231,223 0.31% of shares | low |
| Jan 7, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $227.8K | -3K -1.28% | 228,269 0.30% of shares | medium |
| Mar 4, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $226.8K | -3K -1.50% | 212,048 0.28% of shares | medium |
| Feb 4, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $161.0K | -2K -1.15% | 214,167 0.28% of shares | medium |
| Mar 4, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $149.4K | -2K -0.98% | 209,973 0.28% of shares | medium |
| Mar 4, 2026 | Exercise | APGE Apogee Therapeutics, Inc. Common Stock | $94.3K | +4K +1.95% | 215,273 0.28% of shares | low |
| Feb 4, 2026 | Exercise | APGE Apogee Therapeutics, Inc. Common Stock | $94.3K | +4K +1.94% | 216,648 0.29% of shares | low |
| Aug 5, 2026 | Exercise | APGE Apogee Therapeutics, Inc. Common Stock | $94.3K | +4K +2.43% | 173,998 0.23% of shares | low |
| Feb 4, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $93.5K | -1K -0.66% | 212,747 0.28% of shares | low |
| Feb 4, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $86.8K | -1K -0.61% | 211,448 0.28% of shares | low |
| Jan 7, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $65.3K | -826 -0.39% | 212,623 0.28% of shares | low |
| Mar 4, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $14.7K | -200 -0.10% | 209,773 0.28% of shares | low |
| Feb 4, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $13.8K | -200 -0.09% | 211,148 0.28% of shares | low |
| Jan 7, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $8.0K | -100 -0.05% | 212,523 0.28% of shares | low |
| Feb 4, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $6.8K | -100 -0.05% | 211,348 0.28% of shares | low |
| Jan 23, 2026 | Other | ORKA Oruka Therapeutics, Inc. Common Stock | $0 | +116K | 116,483 0.18% of shares | low |
| Mar 4, 2026 | Exercise | APGE Apogee Therapeutics, Inc. Stock Option (Right to Buy) | — | -4K -3.05% | 131,290 0.17% of shares | low |
| Feb 4, 2026 | Exercise | APGE Apogee Therapeutics, Inc. Stock Option (Right to Buy) | — | -4K -2.96% | 135,415 0.18% of shares | low |
| Jan 7, 2026 | Exercise | APGE Apogee Therapeutics, Inc. Stock Option (Right to Buy) | — | -14K -9.13% | 139,540 0.18% of shares | low |
| Jan 2, 2026 | Grant | APGE Apogee Therapeutics, Inc. Stock Option (Right to Buy) | — | +84K | 83,690 0.11% of shares | low |
| Aug 5, 2026 | Exercise | APGE Apogee Therapeutics, Inc. Stock Option (Right to Buy) | — | -4K -3.59% | 110,665 0.15% of shares | low |